2m 2m 2m 2m 2m 2m 2m
Jade Biosciences (JBIO)
NASDAQ
$14.74-$0.17 (-1.11%)
Price as of Oct 23, 2026 1:10 PM EDT- $948.2MMarket Cap
- 50.15%1-Year Change
- BiotechnologyIndustry
Jade Biosciences (JBIO)
$14.74-$0.17 (-1.11%)
JBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.91 | ||
Change | -$0.22 (-1.45%) | ||
Open | $15.04 | ||
High | $15.44 | ||
Low | $14.36 | ||
Previous Close | $15.13 | ||
Volume | 575,925 | ||
30-Day Average Volume | 938,122 | ||
1-Week Change | 8.36% | ||
1-Month Change | -11.04% | ||
1-Year Change | 50.15% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 63.6M | ||
Total Assets | $472.1M | ||
Market Cap | $948.2M | ||
Enterprise Value | $841.0M | ||
Period: QTR TTM FY | |||
Revenue | -$245,000.00 | ||
Net Income | -$55.8M | ||
Free Cash Flow | -$43.7M | ||
EBIT | -$55.8M | ||
EBITDA | -$55.7M | ||
Net Working Capital | $439.7M | ||
EPS | -$0.76 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | -3,433 | ||
P/B | 2 | ||
P/E | -20 | ||
PEG | 1 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue